Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | thyroid stimulating hormone receptor | Starlite/ChEMBL | No references |
Homo sapiens | cytochrome P450, family 2, subfamily D, polypeptide 6 | Starlite/ChEMBL | No references |
Rattus norvegicus | Inositol monophosphatase 1 | Starlite/ChEMBL | No references |
Homo sapiens | cytochrome P450, family 3, subfamily A, polypeptide 4 | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | peptide N-glycanase, putative | 0.0177 | 0.5816 | 0.6472 |
Brugia malayi | O-Glycosyl hydrolase family 30 protein | 0.0249 | 0.8767 | 0.8767 |
Onchocerca volvulus | 0.0177 | 0.5816 | 1 | |
Trypanosoma cruzi | myo-inositol-1(or 4)-monophosphatase 1, putative | 0.0045 | 0.0402 | 0.5 |
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.0059 | 0.0976 | 0.1364 |
Schistosoma mansoni | inositol monophosphatase | 0.0045 | 0.0402 | 0.0691 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0249 | 0.8767 | 1 |
Mycobacterium ulcerans | putative transglutaminase-like protein | 0.0177 | 0.5816 | 1 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0249 | 0.8767 | 1 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0249 | 0.8767 | 1 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0177 | 0.5816 | 1 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0164 | 0.5264 | 0.5813 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0059 | 0.0976 | 0.106 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0059 | 0.0976 | 0.106 |
Echinococcus granulosus | Transglutaminase | 0.0177 | 0.5816 | 1 |
Giardia lamblia | Transglutaminase/protease, putative | 0.0177 | 0.5816 | 0.5 |
Echinococcus granulosus | inositol monophosphatase 1 | 0.0045 | 0.0402 | 0.0691 |
Trypanosoma cruzi | myo-inositol-1(or 4)-monophosphatase 1, putative | 0.0045 | 0.0402 | 0.5 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0249 | 0.8767 | 1 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0177 | 0.5816 | 1 |
Brugia malayi | Thioredoxin family protein | 0.0177 | 0.5816 | 0.5816 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0164 | 0.5264 | 0.5813 |
Mycobacterium ulcerans | hypothetical protein | 0.0177 | 0.5816 | 1 |
Mycobacterium tuberculosis | Hypothetical protein | 0.0177 | 0.5816 | 1 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0164 | 0.5264 | 0.5813 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0249 | 0.8767 | 1 |
Mycobacterium ulcerans | transglutaminase family protein | 0.0177 | 0.5816 | 1 |
Wolbachia endosymbiont of Brugia malayi | fructose-1,6-bisphosphatase | 0.0045 | 0.0402 | 0.5 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0173 | 0.5624 | 0.6243 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0059 | 0.0976 | 0.1678 |
Loa Loa (eye worm) | O-glycosyl hydrolase family 30 protein | 0.0249 | 0.8767 | 0.8715 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0164 | 0.5264 | 0.5813 |
Mycobacterium ulcerans | hypothetical protein | 0.0177 | 0.5816 | 1 |
Giardia lamblia | Hypothetical protein | 0.0177 | 0.5816 | 0.5 |
Brugia malayi | Inositol-1 | 0.0045 | 0.0402 | 0.0402 |
Echinococcus multilocularis | Transglutaminase | 0.0177 | 0.5816 | 1 |
Mycobacterium leprae | Conserved hypothetical protein | 0.0177 | 0.5816 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0177 | 0.5816 | 1 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0173 | 0.5624 | 0.6243 |
Schistosoma mansoni | inositol monophosphatase | 0.0045 | 0.0402 | 0.0691 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.0059 | 0.0976 | 0.1678 |
Entamoeba histolytica | myo-inositol monophosphatase, putative | 0.0045 | 0.0402 | 1 |
Mycobacterium tuberculosis | Conserved protein | 0.0177 | 0.5816 | 1 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0059 | 0.0976 | 0.106 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0164 | 0.5264 | 0.5813 |
Loa Loa (eye worm) | follicle stimulating hormone receptor | 0.028 | 1 | 1 |
Mycobacterium tuberculosis | Long conserved protein | 0.0177 | 0.5816 | 1 |
Echinococcus multilocularis | inositol monophosphatase 1 | 0.0045 | 0.0402 | 0.0691 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0059 | 0.0976 | 0.1678 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0164 | 0.5264 | 0.5813 |
Mycobacterium leprae | Conserved hypothetical protein | 0.0177 | 0.5816 | 1 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0059 | 0.0976 | 1 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0164 | 0.5264 | 0.5813 |
Trypanosoma brucei | inositol-1(or 4)-monophosphatase 1, putative | 0.0045 | 0.0402 | 0.5 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0249 | 0.8767 | 1 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.0059 | 0.0976 | 1 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0059 | 0.0976 | 0.1678 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
AC50 (functional) | PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2c19 Compounds with AC50 equal or less than 10 uM are considered active | ChEMBL. | No reference | |
AC50 (functional) | PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2c9 Compounds with AC50 equal or less than 10 uM are considered active | ChEMBL. | No reference | |
AC50 (functional) | PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp1a2 Compounds with AC50 equal or less than 10 uM are considered active | ChEMBL. | No reference | |
AC50 (functional) | = 15.84893192 uM | PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2d6 Compounds with AC50 equal or less than 10 uM are considered active | ChEMBL. | No reference |
AC50 (functional) | = 19.95262315 uM | PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp3a4 Compounds with AC50 equal or less than 10 uM are considered active | ChEMBL. | No reference |
Potency (functional) | = 10 um | PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 10 um | PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 11.2202 um | PUBCHEM_BIOASSAY: qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium. (Class of assay: confirmatory) [Related pubchem assays: 901 ] | ChEMBL. | No reference |
Potency (ADMET) | = 15.8489 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2D6. (Class of assay: confirmatory) [Related pubchem assays: 410 ] | ChEMBL. | No reference |
Potency (ADMET) | = 19.9526 um | PUBCHEM_BIOASSAY: qHTS Assay for Activators of Cytochrome P450 3A4. (Class of assay: confirmatory) [Related pubchem assays: 410 ] | ChEMBL. | No reference |
Potency (ADMET) | = 19.9526 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4. (Class of assay: confirmatory) [Related pubchem assays: 410 ] | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.